Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

MAb from Hayashibara with IFN-inducing properties

Jan. 23, 1997

Drug screening technology available for licensing

Jan. 22, 1997

n-Docosanol efficacy demonstrated in herpes labialis

Jan. 21, 1997

Shaman patents new antifungal agents

Jan. 21, 1997

Abbott isolates fusacandin antifungal agents

Jan. 20, 1997

Tularik, Merck & Co. extend R&D agreement

Jan. 17, 1997

Takeda discloses lankacidin derivatives

Jan. 17, 1997

Generic version of Monistat-7 approved by FDA

Jan. 16, 1997

New approvals for Zagam

Jan. 16, 1997

Biochemie reports new cephalosporins

Jan. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...